Evidence map›Paper›PMID 37032491›Full record

ArticlePathogens and global health2023

Evaluation of mono and combined nitrofurantoin therapy for toxoplasmosis

Asmaa Elkholy, Rita Wassef, Omnia Alsaid, Mona Elawady, Ashraf Barakat, Ashraf Soror, Shereen Kishik

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens and global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Review
  2. Veterinary sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Asmaa ElkholyParasitology department, Faculty of Medicine, Benha University, Benha, Egypt.
Rita WassefParasitology department, Faculty of Medicine, Helwan University, Cairo, Egypt.ORCID 0000-0002-8431-2428
Omnia AlsaidBiochemistry department, Faculty of Medicine, Benha University, Benha, Egypt.
Mona ElawadyPublic Health department, Faculty of Medicine, Benha University, Benha, Egypt.
Ashraf BarakatZoonotic Diseases department, National Research Centre, Giza, Egypt.
Ashraf SororAnimal Reproduction and Artificial Insemination department, National Research Centre, Giza, Egypt.
Shereen KishikParasitology department, Faculty of Medicine, Benha University, Benha, Egypt.
Benha University · EGNational Research Centre · EGHelwan University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasmosis is a frequent disease with an estimated prevalence of more than one billion human cases worldwide and over one million new infections each year. It is classified as a neglected tropical disease by the CDC since 2019. The disease may pass unnoticed in healthy individuals but could be fatal in the immunocompromised. Moreover, no effective treatment is available against the chronic form of the disease. Available anti-

Indexed as

SpiramycinToxoplasmaToxoplasmosisAnimalsDisease Models, AnimalFemaleHumansMiceNitrofurantoinPersistent InfectionNitrofurantoinSpiramycinIn vivonitrofurantoinToxoplasma gondiitoxoplasmosistreatment

Identifiers

PMID37032491
PMCPMC10498811
OpenAlexW4362732347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.